866-997-4948 (US-Canada Toll Free)

United States Knee Reconstruction Market Outlook to 2020

Published By :

GlobalData

Published Date : 2014-02-10

Category :

Surgical Equipment

No. of Pages : 131

Product Synopsis


GlobalDatas new report, "United States Knee Reconstruction Market Outlook to 2020", provides key market data on the United States Knee Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Primary Knee Replacement, Revision Knee Replacement and Partial Knee Replacement.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Knee Reconstruction market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipmentbased models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipmentbased forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Knee Reconstruction market categories Primary Knee Replacement, Revision Knee Replacement and Partial Knee Replacement. 
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. 
  • 2012 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States Knee Reconstruction market.
  • Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Biomet, Inc., Smith & Nephew Plc, B. Braun Melsungen AG, Exactech, Inc.and Wright Medical Group, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

Table Of Content

Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 8
2.1 What Is This Report About? 8
2.2 Knee Reconstruction Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9

3 Knee Reconstruction Market, United States 10
3.1 Knee Reconstruction Market, United States, Revenue ($m), 2005-2012 10
3.2 Knee Reconstruction Market, United States, Revenue ($m), 2012-2020 12
3.2.1 Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2005-2012 14
3.2.2 Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2012-2020 16
3.3 Knee Reconstruction Market, United States, Volume (Units), 2005-2012 18
3.4 Knee Reconstruction Market, United States, Volume (Units), 2012-2020 20
3.4.1 Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2005-2012 22
3.4.2 Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2012-2020 24
3.5 Knee Reconstruction Market, United States, Average Price ($), 2005-2020 26
3.6 Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), 2011-2012 27
3.7 Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2011-2012 28

4 Overview of Key Companies in United States Knee Reconstruction Market 30
4.1 Zimmer Holdings, Inc. 30
4.1.1 Company Overview 30
4.2 Stryker Corporation 30
4.2.1 Company Overview 30
4.3 DePuy Companies 31
4.3.1 Company Overview 31
4.4 Biomet, Inc. 31
4.4.1 Company Overview 31
4.5 Smith & Nephew Plc 31
4.5.1 Company Overview 31
4.6 B. Braun Melsungen AG 32
4.6.1 Company Overview 32
4.7 Wright Medical Group, Inc. 32
4.7.1 Company Overview 32
4.8 Exactech, Inc. 33
4.8.1 Company Overview 33

5 Knee Reconstruction Market Pipeline Products 34

6 Financial Deals Landscape 35
6.1 Acquisition 35
6.1.1 Zimmer Acquires Knee Creations, Orthopedic Device Company 35
6.2 Asset Transactions 37
6.2.1 MicroPort Completes Acquisition Of OrthoRecon Business From Wright Medical For US$290 Million 37
6.3 Debt Offerings 40
6.3.1 Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 40
6.3.2 Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 42
6.3.3 Biomet Completes Private Placement Of Notes Due 2020 For US$825 Million 44
6.3.4 Biomet Completes Private Placement Of Notes Due 2020 For US$800 Million 46
6.3.5 DJO Global Completes Private Placement Of Notes For US$100 Million 48
6.3.6 DJO Global Completes Private Placement Of Notes Due 2018 For US$440 Million 50
6.3.7 Wright Medical Completes Private Placement Of Notes Due 2017 For US$300 Million 52
6.3.8 Biomet Completes Private Placement Of Senior Notes Due 2020 For US$1,000 Million 54
6.3.9 DJO Global Completes Private Placement Of Notes Due 2018 For US$230 Million 56
6.4 Partnerships 58
6.4.1 OrthoSensor Enters Into Co-Marketing Agreement With Zimmer Holdings 58
6.4.2 Stryker Extends Co-Marketing Agreement With OrthoSensor 60
6.4.3 Biomet Enters Into Co-Promotion Agreement With OrthoSensor 62
6.5 Private Equity 64
6.5.1 Genstar Capital Acquires Tecomet From Charlesbank Capital Partners 64
6.5.2 Private Equity Owners Evaluate Options For Biomet Exit 67
6.6 Venture Financing 69
6.6.1 Histogenics Raises US$10.3 Million In Venture Financing 69
6.6.2 Cayenne Medical Raises US$0.2 Million In Venture Financing 70
6.6.3 NovoPedics Raises US$0.5 Million In Venture Financing 71
6.6.4 Medical Device Innovations Raises US$0.5 Million In Venture Financing 73
6.6.5 Histogenics Raises US$49 Million In Series A Financing 74
6.6.6 Cayenne Medical Raises US$10 Million In Series D Financing 77

7 Recent Developments 80
7.1 Corporate Communications 80
7.1.1 Jan 23, 2014: Amedica Appoints Distinguished Surgical Device And Biomaterials Executive Jeff White To Board Of Directors 80
7.1.2 Dec 16, 2013: Zimmer Holdings Names Paul Bisaro to Board of Directors 80
7.1.3 Oct 14, 2013: Exactech Names Orthopaedic Executive Bill Shopoff as Vice President U.S. Sales; Industry Veteran Bob Purcell Retires After 40+ Years in Healthcare 81
7.1.4 Aug 19, 2013: Orthofix Receives Expected NASDAQ Notice Related to Late Filing of Form 10-Q 81
7.1.5 Jul 18, 2013: MAKO Surgical Corp. Announces Management Changes 81
7.1.6 Jul 08, 2013: MAKO Surgical Announces Additions to Board of Directors 82
7.1.7 Jun 03, 2013: MAKO Surgical Announces Addition of Senior Executive to Management Team 83
7.1.8 May 09, 2013: Zimmer Eliminates Approximately 50 Full Time Jobs 83
7.1.9 Apr 08, 2013: Stryker Names William Jellison As CFO 83
7.1.10 Mar 11, 2013: Amedica Appoints Karl Farnsworth As CFO 84
7.1.11 Feb 25, 2013: Zimmer Spine Launches Zimmer DTO 5.5 System 84
7.1.12 Feb 21, 2013: MAKO Surgical Announces Appointment of Christopher R. Marrus as Senior Vice President of Sales 85
7.1.13 Feb 01, 2013: Endosense’s TactiCath Quartz Contact-Force Sensing Ablation Catheter Used To Perform First Case In US 85
7.2 Financial Announcements 86
7.2.1 Jan 08, 2014: Biomet Announces Second Quarter of Fiscal 2014 Financial Results 86
7.2.2 Dec 16, 2013: Zimmer Announces Fourth Quarter Dividend and New Share Repurchase Program 87
7.2.3 Nov 05, 2013: MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2013 88
7.2.4 Oct 31, 2013: Isolite Systems Launches Isovac Dental Isolation Adapter 89
7.2.5 Oct 29, 2013: ArthroCare Reports Third Quarter 2013 Financial Results 90
7.2.6 Oct 25, 2013: ArthroCare Announces Date for Third Quarter 2013 Financial Results Press Release and Conference Call 92
7.2.7 Oct 24, 2013: Zimmer Holdings Reports Third Quarter 2013 Financial Results 92
7.2.8 Oct 23, 2013: Exactech Q3 Net Income up 25% to $3.2 Million; Diluted EPS $0.23 vs. $0.19; Worldwide Sales Up 9% to $55.7 Million; U.S. Sales Increased 11% 93
7.2.9 Oct 17, 2013: Stryker Reports Third Quarter 2013 Results 94
7.2.10 Oct 10, 2013: Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2013 Results 96
7.2.11 Oct 08, 2013: Devon Medical Announces Global Availability of Foot Dressing for Negative Pressure Wound Therapy 96
7.2.12 Oct 08, 2013: Biomet Announces First Quarter of Fiscal 2014 Financial Results 97
7.2.13 Oct 08, 2013: Exactech Schedules Third Quarter 2013 Earnings Release and Conference Call 99
7.2.14 Sep 24, 2013: Biomet Announces Fiscal Year 2014 First Quarter Conference Call 99
7.2.15 Sep 08, 2013: Successful live case and international recognition for the innovative and unique Urological Stents of Allium Medical 99
7.2.16 Aug 29, 2013: Biomet Announces Fourth Quarter and Fiscal Year 2013 Final Financial Results 102
7.2.17 Aug 05, 2013: ArthroCare Reports Second Quarter 2013 Financial Results 103
7.2.18 Aug 02, 2013: ArthroCare Announces Date for Second Quarter 2013 Financial Results Press Release and Conference Call 105
7.2.19 Jul 30, 2013: MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2013 105
7.2.20 Jul 25, 2013: Zimmer Reports Second Quarter 2013 Financial Results 107
7.2.21 Jul 24, 2013: Exactech Q2 Net Income up 23% to $3.7 Million. Diluted EPS $0.27 vs. $0.23. Worldwide Sales Up 10% to $60.6 Million. U.S. Sales Increased 13% 108
7.2.22 Jul 15, 2013: MAKO Surgical Corp. Schedules Second Quarter 2013 Earnings Release and Conference Call for Tuesday, July 30, 2013 109
7.2.23 Jul 11, 2013: Biomet Announces Fourth Quarter and Fiscal Year 2013 Preliminary Financial Results 109
7.2.24 Jul 10, 2013: Exactech Schedules Second Quarter 2013 Earnings Release and Conference Call 111
7.2.25 Jun 17, 2013: Covidien Announces Publication Of Final Results Of Pipeline Embolization Device Pivotal Study 111
7.2.26 Jun 04, 2013: Neuros Medical Announces Pilot Study Results On Electrical Nerve Block Technology 113
7.2.27 May 30, 2013: DiFusion Completes Series Of In Vitro Tests And An In Vivo Study To Validate Efficacy Of Its CleanFuze 114
7.2.28 May 07, 2013: ArthroCare Reports First Quarter 2013 Financial Results 115
7.3 Government and Public Interest 116
7.3.1 Jan 06, 2014: Zimmer Holdings to Present at 32nd Annual J.P. Morgan Healthcare Conference 116
7.3.2 Jan 06, 2014: ArthroCare Announces Participation in Investor Conference 116
7.3.3 Nov 26, 2013: Stryker R&D executive to speak at clinical research conference on December 4, 2013 117
7.3.4 Nov 25, 2013: ArthroCare Announces Participation in Investor Conference 117
7.3.5 Nov 20, 2013: Biomet to Present at Bank of America Merrill Lynch 2013 Leveraged Finance Conference 118
7.3.6 Sep 05, 2013: MAKO Surgical to Present at the Morgan Stanley Global Healthcare Conference 118
7.3.7 Aug 30, 2013: Stryker to Present at Investor Conference 118
7.3.8 Aug 20, 2013: Zimmer Holdings to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference 118
7.3.9 Aug 20, 2013: Zimmer Holdings to Present at UBS Best of Americas Conference 2013 118
7.3.10 Aug 20, 2013: Zimmer Holdings to Present at Morgan Stanley 2013 Global Healthcare Conference 118
7.3.11 Aug 06, 2013: Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference 118
7.4 Legal And Regulatory 119
7.4.1 Jan 07, 2014: Medical Device Manufacturer Charged With Major Securities Fraud Scheme 119
7.4.2 Aug 16, 2013: Glancy Binkow & Goldberg Announces Class Action Lawsuit Against Orthofix International 119
7.4.3 Mar 19, 2013: Mako Announces Patent Enforcement Actions Against Stanmore Entities 120
7.5 Other Significant Developments 120
7.5.1 Jan 20, 2014: Cataract Surgery With the WaveTec Vision's ORA System Outperforms Conventional Biometry in a Comparative Effectiveness Study Published in the Peer-Reviewed Journal Ophthalmology 120
7.6 Product News 121
7.6.1 Sep 19, 2013: Columbus Knee System and OrthoPilot Navigation System Used in Study That Concludes Navigation as Proven Method for Improved TKA Alignment Accuracy 121
7.6.2 Feb 27, 2013: Hospital for Joint Diseases First In Northeast To Use Sensor-Assisted Device To Enhance Surgical Precision During Total Knee Replacement 122
7.7 Strategy And Business Planning 122
7.7.1 Mar 27, 2013: Biomet Revokes Plans To Spin-off Dental Business 122

8 Appendix 123
8.1 Research Methodology 124
8.1.1 Coverage 124
8.1.2 Secondary Research 124
8.1.3 Primary Research 125
8.1.4 Market Modeling and Forecasting 126
8.1.5 Company Share Analysis 129
8.1.6 Distribution Share Analysis 130
8.2 Expert Panels 130
8.3 GlobalData Consulting 131
8.4 Contact Us 131
8.5 Disclaimer 131

List of Tables


Table 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 11
Table 2: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Table 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 15
Table 4: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 17
Table 5: Knee Reconstruction Market, United States, Volume (Units), Historic, 2005-2012 19
Table 6: Knee Reconstruction Market, United States, Volume (Units), Forecast, 2012-2020 21
Table 7: Primary Knee Replacement Market, United States, Volume (Units), Historic, 2005-2012 23
Table 8: Primary Knee Replacement Market, United States, Volume (Units), Forecast, 2012-2020 25
Table 9: Knee Reconstruction Market, United States, Average Price ($), Historic, 2005-2012 26
Table 10: Knee Reconstruction Market, United States, Average Price ($), Forecast, 2012-2020 26
Table 11: Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 27
Table 12: Knee Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 29
Table 13: Knee Reconstruction Market Pipeline Products 34
Table 14: Zimmer Acquires Knee Creations, Orthopedic Device Company 35
Table 15: MicroPort Completes Acquisition Of OrthoRecon Business From Wright Medical For US$290 Million 37
Table 16: Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 40
Table 17: Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 42
Table 18: Biomet Completes Private Placement Of Notes Due 2020 For US$825 Million 44
Table 19: Biomet Completes Private Placement Of Notes Due 2020 For US$800 Million 46
Table 20: DJO Global Completes Private Placement Of Notes For US$100 Million 48
Table 21: DJO Global Completes Private Placement Of Notes Due 2018 For US$440 Million 50
Table 22: Wright Medical Completes Private Placement Of Notes Due 2017 For US$300 Million 52
Table 23: Biomet Completes Private Placement Of Senior Notes Due 2020 For US$1,000 Million 54
Table 24: DJO Global Completes Private Placement Of Notes Due 2018 For US$230 Million 56
Table 25: OrthoSensor Enters Into Co-Marketing Agreement With Zimmer Holdings 58
Table 26: Stryker Extends Co-Marketing Agreement With OrthoSensor 60
Table 27: Biomet Enters Into Co-Promotion Agreement With OrthoSensor 62
Table 28: Genstar Capital Acquires Tecomet From Charlesbank Capital Partners 64
Table 29: Private Equity Owners Evaluate Options For Biomet Exit 67
Table 30: Histogenics Raises US$10.3 Million In Venture Financing 69
Table 31: Cayenne Medical Raises US$0.2 Million In Venture Financing 70
Table 32: NovoPedics Raises US$0.5 Million In Venture Financing 71
Table 33: Medical Device Innovations Raises US$0.5 Million In Venture Financing 73
Table 34: Histogenics Raises US$49 Million In Series A Financing 74
Table 35: Cayenne Medical Raises US$10 Million In Series D Financing 77
Table 36: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 126

List of Figures


Figure 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 10
Figure 2: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 12
Figure 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 14
Figure 4: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 16
Figure 5: Knee Reconstruction Market, United States, Volume (Units), Historic, 2005-2012 18
Figure 6: Knee Reconstruction Market, United States, Volume (Units), Forecast, 2012-2020 20
Figure 7: Primary Knee Replacement Market, United States, Volume (Units), Historic, 2005-2012 22
Figure 8: Primary Knee Replacement Market, United States, Volume (Units), Forecast, 2012-2020 24
Figure 9: Knee Reconstruction Market, United States, Company Share (%), 2012 28
Figure 10: GlobalData Epidemiology Based Forecasting Model 128
Figure 11: GlobalData Capital Equipment Based Forecasting Model 129
Figure 12: Primary Calls Split by Participants 130

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Cardiovascular Information System Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    The cardiovascular information system (CVIS) is a web-based collection of clinical information and research material software architecture that facilitates decision support, information exchange and scientific advancement of the cardiovascular field. The aim of this CVIS is to endorse an advanced level of evidence-based professional standards in cardiac rehabilitation. CVIS is a data driven patient informatics integrated hemodynamic system that can store all the information related to cardiovascular disease patient. All the information is stored in CVIS for efficient recording and...

  • Nuts And Seeds Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Nuts and seeds are rich in nutritional value and contain essential nutrients like protein, folate, essential minerals, and fiber. Nuts are defined as dried hard shelled fruits with edible kernel, while seeds are embryonic plants enclosed in seed-coat. Edible seeds are derived from cereals, legumes, and nuts. Seeds and nuts cater to a variety of applications. Nuts are eaten raw, used for cooking, pressed for oil that is used in cooking or cosmetics, or roasted as snack food. Seeds provide many cooking oils, spices and condiments, and some important food additives. The nuts and seeds market...

  • Genomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018

    By - Transparency

    Increasing competition in the pharmaceutical industry to develop new drugs, increasing demand for genetically modified crops and animals, and dropping prices of genomic procedures are some of the major growth drivers for the market. Synthetic biology uses the concepts of genomics as an enabling technology to study the gene sequences of organisms and plants and further research initiatives are taken to invent synthetic cells and DNAs with novel applications.  Emergence of such nascent research will help the market grow in the future. The study of the genomes of organisms is...